Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Kurz

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Pharmacoepidemiology and Drug Safety|February 22, 2017
Advancing regulatory science, advancing regulatory practiceXavier Kurz
Pharmacoepidemiology and Drug Safety|April 18, 2020
Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?Jim Slattery, Xavier Kurz
Pharmacoepidemiology and Drug Safety|August 12, 2022
Artificial intelligence in pharmacovigilance: A regulatory perspective on explainabilityLuis Correia Pinheiro, Xavier Kurz
Pharmacoepidemiology and Drug Safety|January 13, 2018
Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)Xavier Kurz, Susana Perez-Gutthann,
Clinical Pharmacology and Therapeutics|April 11, 2019
Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for EuropeAlison Cave, Xavier Kurz, Peter Arlett
European Journal of Clinical Pharmacology|March 7, 2019
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact studyKarin Hedenmalm, Xavier Kurz, Daniel Morales
Clinical Drug Investigation|May 16, 2019
Addendum to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Rob Flynn, Xavier Kurz
Clinical Pharmacology and Therapeutics|April 11, 2019
Barriers and Opportunities for Use of Patient Registries in Medicines RegulationCarla Alonso Olmo, Patricia McGettigan, Xavier Kurz
Drug Safety|June 21, 2022
Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources DatabaseKelly Plueschke, Carla Jonker, Valerie Strassmann, et al.
Drug Safety|May 23, 2018
Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General PracticeJim Slattery, Daniel Morales, Luis Pinheiro, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Pharmacoepidemiology and Drug Safety|February 22, 2017
Advancing regulatory science, advancing regulatory practiceXavier Kurz
Pharmacoepidemiology and Drug Safety|April 18, 2020
Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?Jim Slattery, Xavier Kurz
Pharmacoepidemiology and Drug Safety|August 12, 2022
Artificial intelligence in pharmacovigilance: A regulatory perspective on explainabilityLuis Correia Pinheiro, Xavier Kurz
Pharmacoepidemiology and Drug Safety|January 13, 2018
Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)Xavier Kurz, Susana Perez-Gutthann,
Clinical Pharmacology and Therapeutics|April 11, 2019
Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for EuropeAlison Cave, Xavier Kurz, Peter Arlett
European Journal of Clinical Pharmacology|March 7, 2019
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact studyKarin Hedenmalm, Xavier Kurz, Daniel Morales
Clinical Drug Investigation|May 16, 2019
Addendum to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control StudyDaniel R Morales, Rob Flynn, Xavier Kurz
Clinical Pharmacology and Therapeutics|April 11, 2019
Barriers and Opportunities for Use of Patient Registries in Medicines RegulationCarla Alonso Olmo, Patricia McGettigan, Xavier Kurz
Drug Safety|June 21, 2022
Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources DatabaseKelly Plueschke, Carla Jonker, Valerie Strassmann, et al.
Drug Safety|May 23, 2018
Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General PracticeJim Slattery, Daniel Morales, Luis Pinheiro, et al.
Pageof 8